Protara Therapeutics Inc. (TARA)
Market Closed
17 Jul, 20:00
$
4. 10
+0.02
+0.4902%
$
157.83M Market Cap
- P/E Ratio
- Div Yield
441,500 Volume
-3.57 Eps
$ 4.08
Previous Close 
Want to track TARA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TARA Stock Soars on Superior Efficacy of Bladder Cancer Cell Therapy
Protara stock surges 70% as investigational cell therapy, TARA-002, shows superior six-month efficacy in phase II bladder cancer study.
Zacks | 1 year ago
Why Is Protara Therapeutics Stock Skyrocketing Over 100% On Thursday?
On Thursday, Protara Therapeutics Inc. TARA stock traded higher after the company revealed results from its ongoing Phase 2 open-label ADVANCED-2 trial.
Benzinga | 1 year ago
